by Brian MannFeb, 04 2021 (Morning Edition) OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. The global business consulting firm McKinsey & Company has agreed to a $573 million settlement over its role in the opioid crisis. Image: Toby Talbot/AP McKinsey & Company has reached a $573 million settlement with nearly 50 state governments as well as the District of Columbia and territories, over its role helping to market and boost sales of high-risk opioids including OxyContin. Most of the funds will be devoted to paying for treatment and rehabilitation programs in communitie...